Press Releases Biofrontera Deutsche Boerse AG

Equities

B8F

DE0006046113

Delayed Deutsche Boerse AG Other stock markets 07:18:04 13/05/2024 BST			5-day change	1st Jan Change
0.298 ^EUR	-12.87%		-4.49%	-27.32%

05-15	Earnings Flash (BFRI) BIOFRONTERA Reports Q1 Revenue $7.9M, vs. Street Est of $10.9M	MT
04-30	Biofrontera AG Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BIOFRONTERA AG ANNOUNCES REVISED STRATEGY	02-21	AQ
BIOFRONTERA AG, BIOFRONTERA TRANSFERS CLINICAL RESEARCH TO THE U.S.	02-21	AQ
PTA-News: Biofrontera AG: Biofrontera extends appointment of Management Board member Paul Böckmann	19/08/22	PU
PTA-News: Biofrontera AG: Biofrontera reports financial results for the six months ended June 30, 2022	18/08/22	PU
PTA-DD: Biofrontera AG: Managers' transactions announcement according to article 19 MAR	17/08/22	PU
PTA-News: Biofrontera AG: The request to convene an extraordinary shareholders' meeting by Maruho is not complied with	10/08/22	PU
PTA-News: Biofrontera AG: Maruho Deutschland GmbH demands convening of an extraordinary general meeting	05/08/22	PU
PTA-News: Biofrontera AG: Employees appeal in own statement to the shareholders not to accept the takeover offer of Deutsche Balaton AG	03/08/22	PU
PTA-News: Biofrontera AG: Management Board and Supervisory Board jointly recommend not to accept the takeover offer of Deutsche Balaton AG	29/07/22	PU
PTA-DD: Biofrontera AG: Managers' transactions announcement according to article 19 MAR	28/07/22	PU
PTA-News: Biofrontera AG: Biofrontera AG will publish statement on takeover offer by Deutsche Balaton AG shortly	22/07/22	PU
PTA-DD: Biofrontera AG: Managers' transactions announcement according to article 19 MAR	20/07/22	PU
PTA-News: Biofrontera AG: Biofrontera obtains notice of allowance for Australian patent on innovative PDT treatment protocol	13/07/22	PU
PTA-DD: Biofrontera AG: Managers' transactions announcement according to article 19 MAR	11/07/22	PU
PTA-DD: Biofrontera AG: Managers' transactions announcement according to article 19 MAR	04/07/22	PU
PTA-News: Biofrontera AG: Biofrontera's license partner Louis Widmer receives an extension of its marketing authorization for Ameluz®	08/06/22	PU
PTA-News: Biofrontera AG: Biofrontera reports results for the fiscal year 2021	30/04/22	PU
PTA-News: Biofrontera AG: Biofrontera shifts the publication of the Annual Report 2021 to April 29, 2022	28/04/22	PU
PTA-News: Biofrontera AG: Biofrontera announces conference call to be held on April 29, 2022 to discuss fiscal year 2021 financial results	14/04/22	PU
PTA-News: Biofrontera AG: Governmental price decree for Ameluz® withdrawn in Spain	04/04/22	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Biofrontera Deutsche Boerse AG

Equities

B8F

DE0006046113

Press Releases

Filters